Analysis
PublicCHARTWELL RX LLC holds $76.0M across 516 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 1 related award under parent 36F79720D0198. Competition previously drew 2 offers. Set-aside status: SBA. PoP ended Mar 23, 2026 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.
Contract facts
SBANo full NAICS 325412 intel page yet. Browse NAICS intelligence
DOXYCYCLINE HYCLATE TABLETS AND AMOXICILLIN TRIHYDRATE CAPSULES
Recompete timing
PublicCurrent PoP ended Mar 23, 2026 (147 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Watch this contract — one email →Incumbent footprint
Public recordCHARTWELL RX LLC — $76.0M obligated across 516 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Track this contract
Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.
Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.
See all live recompete landscapes — who else is expiring, and where the openings are.
Open CHARTWELL RX LLC’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.
Frequently asked questions
What is contract 75A50322F80030?
75A50322F80030 (DOXYCYCLINE HYCLATE TABLETS AND AMOXICILLIN TRIHYDRATE CAPSULES) is a Department of Health and Human Services (HHS) award with an estimated value of $139.7M, currently held by CHARTWELL RX LLC. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.
Who is the incumbent on 75A50322F80030?
CHARTWELL RX LLC is the incumbent with $76.0M across 516 related awards in SCOUT’s public footprint. The current period of performance ends Mar 23, 2026.
When does 75A50322F80030 come up for recompete?
SCOUT tracks a period-of-performance end of Mar 23, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →